| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.15▲ | 2.17▼ | 2.19▼ | 2.42▼ | 2.30▼ |
| MA10 | 2.15▼ | 2.21▼ | 2.36▼ | 2.37▼ | 2.61▼ |
| MA20 | 2.16▼ | 2.39▼ | 2.55▼ | 2.41▼ | 3.12▼ |
| MA50 | 2.21▼ | 2.51▼ | 2.38▼ | 2.72▼ | 2.85▼ |
| MA100 | 2.38▼ | 2.38▼ | 2.36▼ | 3.18▼ | 2.78▼ |
| MA200 | 2.57▼ | 2.35▼ | 2.47▼ | 2.99▼ | 3.42▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.027▼ | -0.071▼ | 0.028▲ | -0.158▼ |
| RSI | 34.532▼ | 25.992▼ | 29.453▼ | 41.440▼ | 34.387▼ |
| STOCH | 30.682 | 8.367▼ | 4.738▼ | 47.813 | 11.433▼ |
| WILL %R | -75.000 | -97.030▼ | -97.902▼ | -88.578▼ | -94.017▼ |
| CCI | -95.455 | -80.789 | -99.608 | -63.072 | -86.302 |
|
Tuesday, November 17, 2026 08:39 AM
Mixed Quarter. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) delivered a mixed Q3 2026 performance, with its reported loss of $0.05 per share significantly narrow ...
|
|
Tuesday, November 17, 2026 07:15 AM
NRx Pharmaceuticals (NASDAQ:NRXP) reported higher third-quarter patient revenue and a narrower net loss, while outlining plans to commercialize its first approved drug and advance experimental ...
|
|
Tuesday, November 17, 2026 04:18 AM
FDA approved the Company’s first drug, preservative-free ketamine, ahead of its GDUFA goal date; commercial launch underway with a 17-person sales force New Yale University collaboration supports the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/11/26 | 2.485 | 2.495 | 2.135 | 2.15 | 1,433,673 |
| 19/11/26 | 2.86 | 2.885 | 2.52 | 2.55 | 1,397,394 |
| 18/11/26 | 2.46 | 2.91 | 2.46 | 2.80 | 2,162,095 |
| 17/11/26 | 2.145 | 2.47 | 2.09 | 2.45 | 1,598,434 |
| 16/11/26 | 2.16 | 2.195 | 2.052 | 2.15 | 728,159 |
| 13/11/26 | 2.25 | 2.26 | 2.165 | 2.19 | 1,030,551 |
| 12/11/26 | 2.43 | 2.44 | 2.25 | 2.28 | 605,046 |
| 11/11/26 | 2.39 | 2.50 | 2.36 | 2.44 | 980,128 |
| 10/11/26 | 2.32 | 2.40 | 2.29 | 2.36 | 497,771 |
| 09/11/26 | 2.38 | 2.44 | 2.26 | 2.38 | 878,548 |
|
|
||||
|
|
||||
|
|